CIK 0000882291
- Non-accelerated filer
- Smaller reporting company
AETHLON MEDICAL INC
Sign in to watch- Ticker
- AEMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133632859
- Phone
- +1 619-941-0360
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121
- Former names
- BISHOP EQUITIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-06-13 | Joyce James A CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option | +2,500,000 | 7,588,243 | ||
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −5,500 | $0.82 | $5K | 230,374 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −5,000 | $0.79 | $4K | 225,374 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −3,000 | $0.78 | $2K | 222,374 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −25,000 | $0.77 | $19K | 197,374 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −11,500 | $0.75 | $9K | 185,874 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −36,300 | $0.75 | $27K | 149,574 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −10,000 | $0.75 | $8K | 139,574 |
| 2007-03-29 | BROENNIMAN EDWARD G Director | Sale | −3,700 | $0.75 | $3K | 135,874 |
| 2006-03-22 | BROENNIMAN EDWARD G Director | Sale | −2,500 | $0.89 | $2K | 243,374 |
| 2006-03-22 | BROENNIMAN EDWARD G Director | Sale | −7,500 | $0.89 | $7K | 235,874 |
| 2006-03-21 | BROENNIMAN EDWARD G Director | Sale | −5,000 | $0.90 | $4K | 250,874 |
| 2006-03-21 | BROENNIMAN EDWARD G Director | Sale | −5,000 | $0.89 | $4K | 245,874 |
| 2005-09-09 | Joyce James A CEO - SECRETARY | Grant or award · Stock Options | +2,857,143 | $0.11 | $300K | 5,088,243 |
| 2005-07-01 | Joyce James A CEO - SECRETARY | Returned to the company · Stock Options | −250,000 | $1.90 | $475K | 2,231,100 |
| 2005-02-23 | Leung Calvin M Director | Grant or award · Stock Options | +339,400 | $0.38 | $129K | 349,400 |
| 2005-02-23 | BROENNIMAN EDWARD G Director | Grant or award · Stock Options | +545,225 | $0.38 | $207K | 550,725 |
| 2005-02-23 | BARRY FRANKLYN S JR Director | Grant or award · Stock Options | +545,225 | $0.38 | $207K | 957,725 |
| 2005-02-23 | Tullis Richard Chief Science Officer | Grant or award · Stock Options | +1,734,350 | $0.38 | $659K | 1,989,350 |
| 2005-02-23 | Joyce James A Chief Executive Officer, Secre | Grant or award · Stock Options | +2,231,100 | $0.38 | $848K | 2,481,100 |
Page 18 of 18 · 360 trades